This presentation will explore the clinical features, neurodevelopmental consequences, and pathogenesis of common antenatal drug exposures. The extensive information regarding alcohol exposure will be utilized as a foundation, followed by discussion of prescription drug exposures including antidepressants, anxiolytics, and stimulants.
NCC Category Codes: NIC 3, NNP 4
Purpose of this webinar The Academy of Neonatal Nursing provides clinically current information on the technical, medical, and nursing aspects of neonatal care as well as the legal and ethical implications related to that care. This educational session provides information to nurses and other health care professionals who care for newborn, premature, and ill infants and their families. Specific objectives for this presentation are listed below.
Learners who meet the following requirements for successful completion will earn 1 contact hour of CNE:
Access to a computer with an Internet connection
View 90% or more of either the live or archived webinar
Complete and submit an evaluation of this activity
Identify the common features and neurodevelopmental impact of fetal alcohol syndrome.
Describe the impact of exposure to selective serotonin reuptake inhibitors on the neonate
Recognize the impacts of benzodiazepines in pregnancy and the potential corollaries with prescription sleep aids
Evaluate the acute and chronic impact of illicit and prescription stimulants in newborns and children
The Lead Nurse Planner discloses no relevant financial relationships.
The speaker for this CNE activity, Christopher McPherson, Pharm D discloses no relevant financial relationships
The speaker's materials have been reviewed by the Lead Nurse Planner. It has been determined that the material presented here shows no bias nor demonstrates a conflict with the speaker's financial interests.
The content of this webinar has been developed by the speaker and reviewed by the Lead Nurse Planner. The content has been deemed to reflect the current state of practice.
The Academy of Neonatal Nursing assumes no responsibility or liability for the content presented. Care of the infant should always be individualized and no one source relied upon for information regarding aspects of care.
Provider, Academy of Neonatal Nursing, approved by the California Board of Registered Nursing, Provider #CEP 6261; and Florida Board of Nursing, Provider #FBN 3218, content code 2505.
The Academy of Neonatal Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Date of presentation: 3/8/2017 Expiration: 3/8/2020